Table 2.
Studies comparing survival rates in N0 vs. N+ patients over the last 20 years. Difference of values in bold is statistically significant.
| Author | N pts | Type of Tumor (%) | OS | |||||
|---|---|---|---|---|---|---|---|---|
| T | TC | NETT | Overall (mo) | 5Y (%) | 10Y (%) | |||
| Weksler [6] | 229 | - | 76.9 | 23.1 | N0 | 124 | ||
| N+ | 47 | |||||||
| Weksler [7] | 442 | 100 | - | - | N0 | 144 | 79 | 32 |
| N+ | 98 | 66 | 16 | |||||
| Gu [2] | 1617 | 81 | 16.4 | 2.6 | N0 | 92.5 | ||
| N+ | 51.9 | |||||||
| Song [26] | 362 | - | 66.3 | 33.7 | N0 | 81 | ||
| N+ | 46 | |||||||
| Wang [27] * | 398 | - | 78.6 | 21.4 | N0 | 86 | 37 | |
| N+ | 41 | 6 | ||||||
* Intentional lymphadenectomy; T: thymoma; TC: thymic carcinoma; NETT: thymic neuroendocrine tumor; OS: overall survival; 5Y: five years survival rate; 10Y: ten years survival rate.